Isthmin (ISM) is a 60 kDa secreted-angiogenesis inhibitor that suppresses tumor growth in mouse and disrupts vessel patterning in zebrafish embryos. It selectively binds to alphavbeta5 (avb5) integrin on the surface of endothelial cells (ECs), but the mechanism of its antiangiogenic action remains unknown. In this work, we establish that soluble ISM suppresses in vitro angiogenesis and induces EC apoptosis by interacting with its cell surface receptor avb5 integrin through a novel 'RKD' motif localized within its adhesion-associated domain in MUC4 and other proteins domain. ISM induces EC apoptosis through integrinmediated death (IMD) by direct recruitment and activation of caspase-8 without causing anoikis. On the other hand, immobilized ISM loses its antiangiogenic function and instead promotes EC adhesion, survival and migration through avb5 integrin by activating focal adhesion kinase (FAK). ISM unexpectedly has both a pro-survival and death-promoting effect on ECs depending on its physical state. This dual function of a single antiangiogenic protein may impact its antiangiogenic efficacy in vivo. Cell Death and Disease (2011) 2, e153; doi:10.1038/cddis.2011.37; published online 5 May 2011
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Subject Category: Experimental medicine Angiogenesis, formation of new blood vessels from preexisting capillaries, is critical for embryonic development, wound healing, reproduction, as well as tumor progression and metastasis. 1 Angiogenesis inhibitors hence offer new promises as therapeutic agents for cancer therapy. In vivo, angiogenesis is believed to be regulated by a balance of pro and antiangiogenic factors. Although a number of endogenous angiogenesis inhibitors such as thrombospondin-1 (TSP-1) and endostatin have been discovered, the full spectrum of angiogenesis inhibitors in vivo and how they regulate angiogenesis remain to be fully elucidated. 2 Isthmin (ISM), a 60 kDa secreted matricellular protein, was originally identified as a gene highly expressed in the midbrain-hindbrain organizer in Xenopus embryos. 3 It contains a centrally located thrombospondin type 1 repeat (TSR) domain and a C-terminal domain called adhesion-associated domain in MUC4 and other proteins (AMOP). We recently reported that ISM is a novel endogenous angiogenesis inhibitor with functions in both physiological and pathological angiogenesis. 4 It suppresses multiple aspects of in vitro angiogenesis including endothelial cell (EC) capillary network formation on Matrigel and EC proliferation. It also induces EC apoptosis. In mice, overexpression of ISM in B16 melanoma cells inhibited tumor growth and angiogenesis. Knockdown of ISM in zebrafish embryos led to abnormal intersegmental vessel (ISV) formation in the trunk. 4 Although ISM was shown to selectively bind to alphavbeta5 (avb5) integrin, the mechanism of its antiangiogenic action is still largely unclear.
To decipher ISM's mechanism of action, we addressed the following questions in this work: (1) 
Results
Soluble ISM inhibits angiogenesis and induces EC apoptosis through avb5 integrin. We have previously reported that soluble ISM produced from E. coli functions as an angiogenesis inhibitor, inhibiting EC tube formation, inducing EC apoptosis and suppressing vascular endothelial growth factor (VEGF)-stimulated EC proliferation in a dosedependent manner. 4 We also found that ISM selectively binds to avb5, but not other integrins expressed in ECs. 4 We show here that recombinant ISM protein produced from cultured mammalian cells (HEK293 T) has similar antiangiogenic and apoptosis-induction activity (Supplementary Figure S1 ). Because of cost-effective production, recombinant ISM made from bacteria is used in this study.
As avb5 integrin is a cell surface receptor of ISM, we wish to determine whether ISM inhibits angiogenesis and induces apoptosis through this integrin. In ECs (human umbilical vein endothelial cells, HUVEC) used in this study, integrin b3 or b5 subunit only pairs with av subunit, with avb3 expressed at a much higher level than avb5. 5, 6 Knockdown of b3 or b5 integrin subunit expression in ECs had no effect on cell adhesion on gelatin, FN or collagen I (data not shown), possibly due to the presence of b1 integrins such as a5b1 in these cells. It is known that b1 integrin mediate cell adhesion to gelatin, FN and collagen I. 7 Hence the effect of knockdown of b3 or b5 integrin subunit expression on ISM-mediated inhibition of EC tube formation and induction of apoptosis was carried out in cells seeded on gelatin. As shown in Figure 1a , introduction of siRNA significantly reduced b3 and b5-integrin expression up to 70% in ECs. However, only knockdown of b5-integrin expression alleviated ISM-mediated inhibition of tube formation (Figure 1b) . Similarly, ISM-induced EC apoptosis was selectively suppressed by b5, but not b3-knockdown (Figure 2a ). In the absence of ISM, knockdown of these integrins did not induce apoptosis. Similarly, only knockdown of b5-integrin expression significantly rescued ISM-mediated inhibition of VEGF-induced EC proliferation (Figure 2b ). These results demonstrate that avb5 integrin has an essential role in ISM-mediated angiogenesis inhibition and apoptosis.
As avb5 is essential for ISM-induced apoptosis, the amount of free avb5 available for ISM binding should correspond to the extent of EC apoptosis. In ECs attached on VN-or ISM-coated surface, both ligands of avb5 integrin, the free avb5 available for soluble ISM binding are reduced, comparing with ECs attached on FN-coated surface (Figure 2c ), most likely due to avb5 occupancy by VN or ISM. Correspondingly, soluble ISM induced only marginal apoptosis in ECs attached on VN and ISM, compared with significant apoptosis with ECs attached on FN (Figure 2d) .
Together, these results demonstrate that soluble ISM suppresses angiogenesis and induces EC apoptosis through interacting with avb5 integrin on EC surface without causing anoikis. The extent of ISM-induced apoptosis depends on the number of free avb5 integrin on EC surface that are available for soluble ISM binding.
Soluble ISM induces EC apoptosis through IMD. It is known that certain cyclic RGD peptides 8 or non-peptide RGD mimetics 9 induce EC detachment from adhered surface (de-adhesion) through binding to integrins, and hence causing apoptosis through anoikis. To determine whether ISM induces EC apoptosis through anoikis, we examined whether ISM induces detachment of adherent ECs. The adhesion of ECs on different immobilized ECM proteins is mediated by distinct integrins. For example, EC adhesion to VN is mediated primarily by avb3 and avb5 integrins, whereas EC adhesion to FN occurred mainly through a5b1 integrin. 5 As shown in supplementary (Supplementary Figure S2) , ISM added into the culture media did not induce 4 and Figure 2a ). We previously established that ISM induces EC apoptosis through a caspase-dependent pathway. 4 To further decipher the mechanism of ISM-induced apoptosis, we used specific inhibitors for caspase-3, -8 and -9 to block the extrinsic and intrinsic apoptosis pathways. As shown in Figure 3a , caspase-3 and -8 inhibitors effectively prevented ISM-induced apoptosis, whereas caspase-9-specific inhibitor had no effect. A gradual activation of caspase-8 and caspase-3 under ISM treatment was observed (Figure 3b ). The active form of caspase-8 (20 kDa) was first detected at 4 h post ISM treatment, whereas activated caspase-3 was first detected after 16 h ISM treatment. No cleaved form of caspase-9 was detected even after 24 h treatment. As a hallmark indicator of apoptosis, the cleaved form of poly ADP ribose polymerase (PARP, 87 kDa) was also found to gradually increase ( Figure 3b ). Activation of caspase-8 and caspase-3 by ISM depends on avb5 integrin as knockdown of b5 integrin by siRNA-suppressed ISM-induced caspase activations and PARP cleavage (Figure 3c ). These results established that ISM induces apoptosis via the extrinsic apoptosis pathway through caspase-8 activation.
It has been previously reported that unligated or antagonized integrin can cluster on cell surface and subsequently recruit caspase-8 to plasma membrane, where it becomes activated in a death receptor-independent manner, a phenomenon termed IMD. 10 To determine if ISM initiates apoptosis through IMD, co-immunoprecipitation was performed to examine the interaction between avb5 integrin and caspase-8. As shown in Figure 3d , ISM induced the association of procaspase-8 (55 kDa) and activated caspase-8 (20 kDa) with avb5 integrin. A Fas antagonist did not prevent ECs from ISM-induced apoptosis, indicating that Fas is not involved in ISM-induced cell death (Supplementary Figure  S3) . Correspondingly, Fas-associated protein with death domain (FADD) was not detected in ISM-induced coimmunoprecipitate sample (data not shown), indicating that FADD is not involved. We therefore conclude that soluble ISM act as a avb5-integrin antagonist and induce EC apoptosis through IMD.
We found that soluble ISM induced integrin clustering ( Figure 3E ), with EC bound ISM (green) and integrin b5-subunit (red) co-localized in cell periphery in clusters. The clustered integrin may be responsible for the recruitment and activation of caspase-8.
Immobilized
ISM promotes EC survival and migration. After its secretion, ISM could potentially exist in different physical states in vivo, such as immobilized in the ECM of a tissue or soluble in circulation. Indeed, we detected ISM in the mouse plasma (98 nM) and the ECM (in Matrigel, 91.5 nM). Interestingly, when ISM was mixed with Matrigel, it lost the ability to inhibit EC tube formation. Soluble ISM at 1 mM in culture medium completely abolished EC tube formation on Matrigel, whereas immobilized ISM in Matrigel had no effect on tube formation even at 3 mM (Figure 4) .
Integrin-mediated cell attachment on immobilized ECM ligands such as FN or VN results in cell spreading, focal adhesion and actin stress fiber formation, as well as activation of focal adhesion kinase (FAK). 11 To determine if immobilized ISM could also function as a cell adhesion molecule and support EC survival, we plated ECs onto ISM-coated surface. As shown in Figure 5a , immobilized ISM supported EC Figure 5B, panels a and b). The adhesion and spreading was completely abolished in the presence of 10 mM EDTA, consistent with the fact that divalent cations are essential for integrin-mediated cell adhesion 11 ( Figure 5B, panels c and d). ECs attached on ISM-coated surface proliferate at similar rate, compared with ECs attached on VN or gelatin (data not shown). Immobilized ISM also induced actin stress fiber formation and integrin clustering, similar to VN ( Figure 5B , panels e-h). Therefore, immobilized ISM supports EC adhesion and survival as a cell adhesion molecule.
We further demonstrated that ECs adhere to ISM-coated surface through avb5 integrin, as avb5 blocking antibody blocked 85% of this adhesion, whereas control IgG or avb3 blocking antibody had no blocking activity (Figure 5c ). Anti-av or anti-b5-subunit antibody also blocked EC adhesion to ISM-coated surface by 56 and 61%, respectively, whereas anti-b1 and anti-b3 antibody had no effect. Collectively, these results confirmed that avb5 integrins mediate EC adhesion to ISM and serves as receptor for immobilized ISM. In comparison, EC attachment to collagen I was inhibited by anti-b1(50%), or attachment to VN was inhibited by anti-avb3(51%) and anti-avb5(29%), respectively, consistent with the ligand-receptor specificity (Supplementary Figure S4,  A and B) .
Knockdown of either b3 or b5-integrin subunit expression by 50-70% through siRNA significantly suppressed cell adhesion on VN-coated surface (Figure 5d) , with b3-knockdown having more potent suppression (Figure 5d ). This is consistent with the much higher level of b3 integrin expression in HUVECs and the fact that avb3 is the main VN receptor. 6, 12 In contrast, only knockdown of b5 integrin reduced cell adhesion to ISMcoated surface, consistent with ISM as a avb5 specific ligand (Figure 5e ). Correspondingly, knockdown of b3 or b5 integrin subunits had no effect on EC adhesion to type I collagen, FN and gelatin (data not shown).
FAK is an important mediator of cell survival, proliferation and migration. 13 Integrin clustering leads to FAK phosphorylation and subsequent recruitment to focal adhesions.
14 The most crucial site for FAK activation is Y397, which is an Srcbinding site. Comparing with cells in suspension, immobilized ISM induced FAK Y397 phosphorylation, similar to immobilized VN (Figure 6a) . Notably, immobilized ISM no longer induces EC apoptosis and present similar basal level apoptosis as immobilized VN, suggesting that immobilized ISM functions as an integrin agonist and transmit positive intracellular signals (Supplementary Figure S5) .
ECs migrate towards a higher concentration of anchored cell adhesion molecule, a phenomenon termed haptotaxis. Immobilized ISM induced EC haptotactic migration in a concentration-dependent manner with similar potency as FN (Figure 6b ). This haptotactic migration is blocked by anti-av, anti-b5 and anti-avb5 antibodies, but not by anti-b1, anti-b3 or anti-avb3 antibodies (Figure 6c Figure S6) . We have previously determined that ISM binds to avb5 integrin through its C-terminal AMOP domain, and the AMOP domain alone can inhibit EC tube formation in vitro. 4 However, there is no 'RGD' sequence within the AMOP domain of ISM. To determine how ISM binds to avb5 integrin, we produced recombinant proteins, corresponding to overlapping N-and C-terminal truncations of AMOP domain (Figure 7a ). ECs attached to AMOP-N coated surface with similar efficacy as the intact AMOP domain, whereas AMOP-C could not support EC attachment at all (Figure 7b ). It has been reported that substitution of G for K in the RGD motif of a 12 residue synthetic hepatitis-A peptide did not change the physiochemical properties of the peptide. 15 However, it is not known if 'RKD' can function as an integrin binding motif. In AMOP-N, there is an 'RKD' motif at amino acids 315-317. We mutated the 'KD at 316-317 position to AA' and produced the mutant AMOP KD316AA protein in the intact AMOP background (Figure 7a ). As shown in Figure 7b , AMOP KD316AA completely lost the ability to support EC adhesion. Furthermore, AMOP KD316AA also lost the ability to inhibit EC tube formation on Matrigel (Figure 7c ). These results demonstrate that ISM binds to EC surface avb5 integrin through a novel 'RKD' motif located in its C-terminal AMOP domain. This motif has a critical role in the antiangiogenic as well as pro-survival functions of ISM. 'RKD' is therefore a novel integrin-binding motif, which binds avb5, but not avb3 integrin.
Discussion
In this work, we demonstrated that the recently identified matricellular angiogenic inhibitor ISM functions through its cell surface receptor avb5 integrin. Although soluble ISM suppresses EC tube formation and induces EC apoptosis as an integrin antagonist, immobilized ISM functions as an integrin agonist and promotes cell survival and migration. The antiangiogenic activity of ISM is lost when ISM is immobilized in ECM. We demonstrated that mouse ISM is present in soluble (plasma) and immobilized form (extracellular matrix), thus its dual activity may have an important role in vivo.
We also identified a novel avb5-integrin-binding site 'RKD' located in the AMOP domain of ISM. Loss of avb5 binding through point mutations of this 'RKD' motif obliterated the antiangiogenic activity of ISM in vitro and abolished the ability of ISM to support EC adhesion. Therefore, integrin avb5 has an essential role in the antiangiogenic as well as pro-survival functions of ISM. This dual function of ISM through the same cell surface integrin receptor and the intracellular signaling pathways involved are summarized in Figure 8 . As avb5 integrin is upregulated in tumor blood vessels, ISM most likely inhibits tumor angiogenesis through this integrin in vivo.
Similar to VN, immobilized ISM promoted EC attachment and spreading, integrin clustering, actin stress fiber formation, FAK activation and EC haptotactic migration ( Figures 5   and 6 ). The clustering of integrins upon ECM engagement is known to transmit positional cues from ECM to intracellular signaling cascades that promote cell survival.
14 Both neutralizing antibody to avb5 integrin, as well as siRNA knockdown of b5 integrin, abrogated EC adhesion to immobilized ISM, demonstrating that immobilized ISM is an avb5 integrin agonist ( Figure 5) .
Different from VN, soluble ISM inhibits in vitro angiogenesis, induces EC apoptosis and suppresses EC proliferation in an avb5 integrin-dependent manner (Figures 1 and 2 ). Figure S6) . We further demonstrated that ISM induces apoptosis through IMD by recruiting caspase-8 to the plasma membrane and activating caspase-8 in a Fas-independent manner. Both the zymogen and active forms of caspase-8 are found in the avb5 protein complex upon ISM induction of apoptosis (Figure 3d ). Soluble ISM therefore serves as an integrin antagonist and transmits a direct death signal involving caspase-8 and caspase-3. This is similar to IMDs induced by RGD containing avb3 integrin antagonist echistatin or overexpression of unligated avb3 integrins. 10, 16 In contrast to previous report that b5 integrin is non-apoptotic, 10 our results provide the first evidence that b5 integrin also mediates IMD.
Both soluble and immobilized ISM induces avb5-integrin clustering ( Figures 3E and 5B) . Although clustering of unligated or antagonized integrins is known to induce apoptosis in adherent cells, clustering of agonized integrin promotes cell survival. 17 Whether soluble and immobilized ISM induce different mode of integrin clustering which lead to different interactions with focal adhesion proteins and activate different intracellular signaling pathways warrant further investigation.
The full spectrum of Ism's physiological role is not clear at this moment. Our preliminary investigation indicated that Ism is expressed at a significantly higher level in lung, comparing with other tissues (Supplementary Figure S7) . Future investigation by immunohistochemistry is needed to reveal how ISM is presented to ECs in vivo.
The phenomenon that an endogenous antiangiogenic protein in different physical state (soluble versus immobilized) carries out contrasting functions in angiogenesis may impact the in vivo efficacy of the antiangiogenic protein. This dualfunction characteristic may also exist in other endogenous antiangiogenic proteins. For example, immobilized endostatin has been reported to support EC adhesion in an integrindependent manner, whereas soluble endostatin inhibits integrin-dependent cell functions such as cell migration and induces apoptosis. 18 It seems that integrin can promote or suppress apoptosis depending on the physical state of its ligand. This characteristic places integrin as a type of dependence receptors that require immobilized ligands to promote cell survival, whereas soluble ligands act as antagonists inducing IMD. 16, 19 In contrast to ISM, ECM adhesion molecules such as VN or FN, which serve as integrin agonists when immobilized, do not function as antagonists to trigger apoptosis in soluble state.
Concluding remarks.
In this work, we demonstrated that the endogenous angiogenesis inhibitor ISM could function as either antagonist or agonist of avb5 integrin and modulate EC apoptosis and survival. Although immobilized ISM promotes EC survival and haptotactic migration, soluble ISM suppresses EC tube formation and induces EC apoptosis through IMD. This study also identified a novel 'RKD' motif within the AMOP domain of ISM, which mediates the specific binding of ISM to avb5, but not avb3. As other endogenous angiogenesis inhibitor proteins may behave in similar fashion, it is conceivable that an antiangiogenic protein may inhibit or promote angiogenesis depending on its physical state in vivo. This may impact on the in vivo efficacy of the antiangiogenic proteins as anticancer drugs.
Materials and Methods
Cell culture and recombinant protein production. Endothelial cells (ECs) used in this work are HUVECs. Fresh umbilical cords were collected from consented maternal ward patients at the National University Hospital according to the protocol (DSRB C/00/553), which is approved by Singapore National Healthcare Group's Domain-Specific Review Board (DSRB) ethics approval committee. ECs were cultured in CSC complete medium (Cell System Corporation, Kirkland, WA, USA). Only cells of passages 4-8 were used in experiments. Cell attachment assays. The assays were performed as described previously, with minor modifications. 20 96-well plates (Nunc, Rochester, NY, USA) were coated with the indicated concentrations of ISM or ECM proteins (Sigma, St. Louis, MO, USA) at 41C overnight. Nonspecific binding sites were blocked with 1% BSA. Subconfluent ECs were harvested and suspended in CSC basal medium. Cells (2 Â 10 4 ) were plated to each well and allowed to attach for 60 min at 37 1C in CO2 incubator. In some experiments, ECs were pre-incubated for 30 min with integrin-specific antibodies (av antibody (clone M9), b1 antibody (clone P4C10), b3 antibody (clone 25E11), b5 antibody (clone E19), avb3 antibody (clone LM609), avb5 antibody (clone P1F6)) (Millipore, Billerica, MA, USA) or control IgG prior to their addition to the wells. After removal of the nonattached cells by washing with PBS, attached cells were fixed with 10% formalin (Sigma) and stained with 0.2% crystal violet. The crystal violet was extracted by 10% acetic acid and cell attachment was quantified by measuring the absorbance of eluted dye at 595 nm with a microplate reader.
Apoptosis assays. ECs (1 Â 10 4 cells per well) in 96-well plate were starved in basal CSC medium containing 2% FBS overnight before treated with 1 mM ISM and 15 ng/ml VEGF for 24 h. Apoptosis was determined by measuring cytosolic oligonucleosome-bound DNA using a Cell Death ELISA kit (Roche Diagnostics Asia Pacific, Singapore). Caspase inhibitors Z-DEVD-FMK (caspase 3 inhibitor), Z-IEDT-FMK (caspase 8 inhibitor), Z-LEHD-FMK (caspase 9 inhibitor) and Kp7-6 (Fas antagonist) (Merck, Singapore) were added to cells 1 h prior to treatment with ISM and VEGF.
Cell proliferation assay. ECs or siRNA transfected ECs (2 Â 10 4 per well) were seeded in a gelatin-coated 96-well plate with CSC complete medium for 24 h at 37 1C and 5% CO2. Cells were starved with CSC basal medium supplemented with 2% FBS overnight. Then 1 mM ISM and 15 ng/ml VEGF were added at the beginning of the proliferation assay. ECs were allowed to proliferate for 24 h and ELISA measurement of free avb5 integrin. A total of 96-well plates were coated with VN (50 mg/ml), FN (50 mg/ml) and ISM (1 mM) at 371C for 2 h. Nonspecific binding sites were blocked with 1% BSA in PBS for 2 h at room temperature. HUVECs (2 Â 10 4 cells) were seeded into each well and allowed to attach overnight. After removal of the nonattached cells by washing with PBS, ECs were fixed and blocked with 3% BSA prior to incubating with anti-avb5 antibody (clone P1F76, Santa Cruz, Santa Cruz, CA, USA) for 1 h. Detection of integrin was achieved by anti-mouse IgG-HRP and developed with TMB (3,3 0 ,5,5 0 -tetramethylbenzidine) (Dako, Glostrup, Denmark) for 15 min. The reaction was stopped with the addition of 50 ml 1 M H 2 SO 4 . The absorbance was then determined at 450 nm.
Immunofluorescence staining. ECs were plated for 2 h on 96-well plates coated with 20 mg/ml of either VN or ISM. Cells were rinsed with PBS twice, fixed with 4% paraphormaldehyde in PBS, permeabilized with 0.1% Triton X-100 in PBS for 10 min and blocked with 3% BSA for 1 h at room temperature. Cells were stained with rhodamine-conjugated phalloidine (actin stress fibers) or goat anti-b5 antibody (Santa Cruz) with FITC-labeled rabbit anti-goat IgG (Invitrogen, Carlsbad, CA, USA) and counter-stained with DAPI (Sigma). For ISM binding to ECs, cells were incubated with ISM for 1 h at 371C and 5% CO 2 before they are fixed and stained with mouse anti-His tag (sc-57598, Santa Cruz) and goat anti-b5 (sc-5401, Santa Cruz) in 3% BSA for 1 h. ISM and b5 integrin were then visualized with a mix of Alexa Fluor 488 rabbit anti-mouse IgG and Alexa Fluor 568 rabbit anti-goat IgG (Invitrogen). Fluorescence images were obtained with a Zeiss laser scanning confocal microscope system (Carl Zeiss South East Asia, Singapore).
RNAi mediated gene silencing. siRNAs were purchased from 1st BASE (Singapore): siRNA targeting human b3 integrin subunit mRNA (5 0 -CAAGCCUG UGUCACCAUAC-dTdT-3 0 ); human b5 subunit integrin mRNA (5 0 -GCUCGCAG GUCUCAACAUA-dTdT-3 0 ); and a random sequence control siScramble (5 0 -GACGUGGGACUGAAGGGGU-dTdT-3 0 ) were as described before.
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Determination of caspase activation by immunoblot. Activation of caspases 3, 8, and 9 was determined as a function of procaspase cleavage. 22 ECs (1 Â 10 5 /ml) were incubated with ISM (1 mM) and VEGF (15 ng/ml) for 24 h. Caspase activation and PARP cleavage were analyzed at 0, 2, 4, 8, 16 and 24 h post ISM-treatment. Cell lysates were separated by SDS-PAGE and probed with antibodies to caspase 3 (R&D systems, Minneapolis, MN, USA), caspase 8, caspase 9, PARP (Millipore).
Co-immunoprecipitation. ECs were incubated with 1 mM ISM for 16 h at 371C, 5% CO2. After removing the unbound ISM, cells were washed, lysed and cell lysates were incubated with anti-avb5 antibody, control IgG and protein A/G Sepharose beads (Santa Cruz) for 2 h at 41C. The precipitates were resolved and analyzed for the presence of caspase-8 or FADD by immunoblotting.
Cell haptotaxis assay. Haptotactic cell motility was measured by using 8 mm cell culture inserts, as previously described. 23 The undersurface of the membrane filter was pre-coated with serial concentration of BSA, ISM or FN. ECs (1 Â 10 6 cells/ml) were added to each insert. The cells were allowed to migrate for 6 h at 371C and 5% CO2 before being fixed and stained with crystal violet. Cell migration was quantified by measuring the absorbance of eluted crystal violet at 560 nm. Antiintegrin antibodies were used at 10 mg/ml in the antibody-neutralization experiments.
Determination of integrin binding site of ISM. AMOP-N and AMOP-C region were cloned into pET-M vector (as described in reference 4) using the following primers: AMOPF1EcoRl: CCGGAATTCCGGCTGCTTGCGGG AAGTGA GGAGT; AMOPR1Xhol: CCGCTCGAGCGGCTCCAGGGACAGCATAGA GCGGA; AMOPF2EcoRl: CCGGAATTCCGGTGCATCCGCTCTATGCTGTCCCT; AMOPR2Xhol: CCGCTCGAGTCGGTCTGGCTTCTTGGAACTGTTTG. The point mutants denoted AMOPKD316AA was obtained from a pET-M-AMOP plasmid using site-directed mutagenesis procedures (Stratagene, La Jolla, CA, USA). The recombinant proteins were expressed in E.coli (BL21DE3) and purified using Ni-NTA affinity chromatography in 6 M urea, according to the manufactures' instructions (Promega, Madison, WI, USA). The proteins were then further purified by reverse-phase HPLC. Protein concentration was determined using BioRad Bradford assay reagent 
